John Wang

2.4k total citations
81 papers, 1.4k citations indexed

About

John Wang is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, John Wang has authored 81 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 21 papers in Surgery and 20 papers in Molecular Biology. Recurrent topics in John Wang's work include Cancer-related Molecular Pathways (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). John Wang is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). John Wang collaborates with scholars based in United States, Taiwan and China. John Wang's co-authors include Chih‐Yi Chen, Ya‐Wen Cheng, De‐Wei Wu, Michael D. Tarantino, William C. Hanigan, Julian Lin, Huei Lee, Huei Lee, Kun-Tu Yeh and Yee‐Jee Jan and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

John Wang

76 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Wang United States 22 519 314 292 287 250 81 1.4k
Yao‐Li Chen Taiwan 23 419 0.8× 315 1.0× 277 0.9× 330 1.1× 407 1.6× 101 1.5k
Lei Gao China 26 770 1.5× 294 0.9× 363 1.2× 190 0.7× 220 0.9× 110 1.8k
Ching Tzao Taiwan 24 658 1.3× 349 1.1× 550 1.9× 311 1.1× 336 1.3× 61 1.7k
Ana Tobar Israel 22 645 1.2× 178 0.6× 192 0.7× 229 0.8× 293 1.2× 51 2.1k
Fabienne Thomas France 26 516 1.0× 829 2.6× 332 1.1× 339 1.2× 265 1.1× 109 2.0k
Ming‐Kuen Lai Taiwan 24 552 1.1× 252 0.8× 512 1.8× 191 0.7× 512 2.0× 80 1.9k
Michael A. Solomon United States 25 535 1.0× 198 0.6× 374 1.3× 273 1.0× 338 1.4× 71 2.0k
Jing Lin China 18 313 0.6× 205 0.7× 219 0.8× 162 0.6× 167 0.7× 73 1.3k
Stefan Stättner Austria 25 467 0.9× 682 2.2× 248 0.8× 322 1.1× 466 1.9× 90 1.6k
Christian Garbar France 24 448 0.9× 419 1.3× 216 0.7× 309 1.1× 291 1.2× 75 1.9k

Countries citing papers authored by John Wang

Since Specialization
Citations

This map shows the geographic impact of John Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wang more than expected).

Fields of papers citing papers by John Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wang. The network helps show where John Wang may publish in the future.

Co-authorship network of co-authors of John Wang

This figure shows the co-authorship network connecting the top 25 collaborators of John Wang. A scholar is included among the top collaborators of John Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Wang. John Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ariyarajah, Archchun, Natasha S. Crowcroft, Kevin A. Brown, et al.. (2025). Measles seroprevalence among individuals serologically tested in Ontario, Canada. Vaccine. 62. 127446–127446.
2.
Zhang, Peiyuan, John Wang, Corey L. Smith, et al.. (2024). Development of an α-Klotho Recognizing High-Affinity Peptide Probe from In-Solution Enrichment. SHILAP Revista de lepidopterología. 4(4). 1334–1344.
3.
Zhang, Peiyuan, John Wang, Hannah T. Baddock, et al.. (2024). Reversibly Reactive Affinity Selection–Mass Spectrometry Enables Identification of Covalent Peptide Binders. Journal of the American Chemical Society. 146(22). 15627–15639. 1 indexed citations
4.
Rössler, Simon L., John Wang, Jason Tao, et al.. (2023). Electrophile Scanning Reveals Reactivity Hotspots for the Design of Covalent Peptide Binders. ACS Chemical Biology. 19(1). 101–109. 5 indexed citations
5.
Jeng, Long‐Bin, John Wang, & Chiao‐Fang Teng. (2023). Predictive Biomarkers of Immune Checkpoint Inhibitor-Based Mono- and Combination Therapies for Hepatocellular Carcinoma. Journal of Cancer. 15(2). 484–493. 2 indexed citations
6.
Zhang, Peiyuan, John Wang, Corey L. Smith, et al.. (2023). Branched Multimeric Peptides as Affinity Reagents for the Detection of α‐Klotho Protein. Angewandte Chemie International Edition. 62(19). e202300289–e202300289. 7 indexed citations
7.
Zhang, Peiyuan, John Wang, Corey L. Smith, et al.. (2023). Branched Multimeric Peptides as Affinity Reagents for the Detection of α‐Klotho Protein. Angewandte Chemie. 135(19). 2 indexed citations
8.
Zhang, Peiyuan, Jason Tao, John Wang, et al.. (2023). Discovery of reactive peptide inhibitors of human papillomavirus oncoprotein E6. Chemical Science. 14(44). 12484–12497. 11 indexed citations
9.
Ramsay, Lauren, John Wang, Theodore K. Marras, et al.. (2020). Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012. Emerging infectious diseases. 26(9). 2097–2107. 8 indexed citations
10.
Bolotin, Shelly, Alberto Severini, Todd F. Hatchette, et al.. (2019). Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study. Human Vaccines & Immunotherapeutics. 15(12). 2856–2864. 12 indexed citations
11.
Huang, Shiu‐Feng, Il‐Chi Chang, Tseng‐Chang Yen, et al.. (2018). Metabolic risk factors are associated with non‐hepatitis B non‐hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B. Hepatology Communications. 2(6). 747–759. 34 indexed citations
12.
Gosling, Andre F., et al.. (2017). Simulation of carotid artery stenting reduces training procedure and fluoroscopy times. Journal of Vascular Surgery. 66(1). 298–306. 12 indexed citations
13.
Liu, Tzu-An, Yee‐Jee Jan, Bor‐Sheng Ko, et al.. (2015). Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma. Oncotarget. 6(36). 38967–38982. 21 indexed citations
14.
15.
Sung, Wen‐Wei, Yao-Chen Wang, Ya‐Wen Cheng, et al.. (2011). A Polymorphic −844T/C in FasL Promoter Predicts Survival and Relapse in Non–Small Cell Lung Cancer. Clinical Cancer Research. 17(18). 5991–5999. 55 indexed citations
16.
Ou, Yen‐Chuan, Chi‐Rei Yang, John Wang, Chen‐Li Cheng, & Vipul Patel. (2011). Learning Curve of Robotic-assisted Radical Prostatectomy With 60 Initial Cases by a Single Surgeon. Asian Journal of Surgery. 34(2). 74–80. 15 indexed citations
17.
Wu, De‐Wei, Ya‐Wen Cheng, John Wang, Chih‐Yi Chen, & Huei Lee. (2010). Paxillin Predicts Survival and Relapse in Non–Small Cell Lung Cancer by MicroRNA-218 Targeting. Cancer Research. 70(24). 10392–10401. 117 indexed citations
18.
Jan, Yee‐Jee, et al.. (2009). A 32‐YEAR‐OLD MAN WITH A FOURTH VENTRICULAR MASS. Brain Pathology. 19(2). 333–336. 3 indexed citations
19.
Li, Jian‐Ri, Chi‐Rei Yang, John Wang, et al.. (2009). Unsuspected Prostate Cancer After Cystoprostatectomy: A Comparison Between Two Periods in Taiwan. Journal of the Formosan Medical Association. 108(5). 409–413. 3 indexed citations
20.
Cheng, Ya‐Wen, Ming‐Fang Wu, John Wang, et al.. (2007). Human Papillomavirus 16/18 E6 Oncoprotein Is Expressed in Lung Cancer and Related with p53 Inactivation. Cancer Research. 67(22). 10686–10693. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yao‐Li Chen Breakdown of academic impact, for papers by Lei Gao Breakdown of academic impact, for papers by Ching Tzao Breakdown of academic impact, for papers by Ana Tobar Breakdown of academic impact, for papers by Fabienne Thomas Breakdown of academic impact, for papers by Ming‐Kuen Lai Breakdown of academic impact, for papers by Michael A. Solomon Breakdown of academic impact, for papers by Jing Lin Breakdown of academic impact, for papers by Stefan Stättner Breakdown of academic impact, for papers by Christian Garbar
Rankless by CCL
2026